Viewpoints Series: A Pharmacist's Perspective on UTIs and Antimicrobial Stewardship
SUMMARY
Proper diagnosis of a UTI remains a clinical conundrum for practitioners, and exposing patients to broad-spectrum antimicrobials can pose significant risks both to the recipient and to public health. With growing MDR (multi-drug resistance) resistance, rapid diagnostics allow pharmacists to escalate therapy quickly to improving patient care and outcomes. Tiffany Bias, PharmD, shares her experiences of diagnosising and treating UTIs and gives her recommendations for optimizing antimicrobial stewardship for UTI patients.
FEATURED EXPERTS
Tiffany Bias, PharmD, BCPS, BCIDP, AAHIVP Director, Antimicrobial Stewardship, eastern US at bioMérieux
GET STARTED
Read the full article here, exclusive to the Learning Lounge.
Take Me There Now
- Filename
- LL-Viewpoints-Series_Pharmacist-Views-on-UTIs-and-Stewardship---Tiffany-Bias_October2021.pdf
- Size
- 190 KB
- Format
- application/pdf
Estimated reading time: 4 minutes
PUBLISHED BY
Learning Lounge Exclusive
November 3, 2021
